Regenxbio (RGNX) Net Margin (2014 - 2026)
Regenxbio (RGNX) recorded Net Margin of 21.02% in Q2 2026, up 352.83 percentage points from -331.81% a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Net Margin (2014 - 2026) Analysis & Trends
On a TTM basis, Regenxbio's Net Margin came in at -93.56% as of Jun 30, 2026, up 19.14 percentage points year-over-year; for FY2025, it was -113.75%, up 158.79 percentage points from FY2024.
- Annual Net Margin has a five-year change of -41.78 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -272.54% in FY2024 (+19.45 pp), -291.99% in FY2023 (-43.31 pp), -248.68% in FY2022 (-275.86 pp) and 27.18% in FY2021 (+99.16 pp).
- The Q2 2026 figure is the highest quarterly Net Margin since Q4 2021.
- On a year-over-year basis, Net Margin rose in five of the last seven quarters, with an average year-over-year change of +105.48 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 412.22 percentage points in Q1 2025, against a drop of 264.96 percentage points in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -1.65% |
| 10 | Regenxbio | 391.13 Mn | -541.96 Mn | - | 21.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.02% |
| Dec 31, 2025 | -221.34% |
| Sep 30, 2025 | -208.32% |
| Jun 30, 2025 | -331.81% |
| Mar 31, 2025 | 6.83% |
| Dec 31, 2024 | -241.28% |
| Sep 30, 2024 | -246.30% |
| Jun 30, 2024 | -237.67% |
| Mar 31, 2024 | -405.39% |
| Dec 31, 2023 | -283.12% |
| Sep 30, 2023 | -213.97% |
| Jun 30, 2023 | -360.72% |
| Mar 31, 2023 | -348.40% |
| Dec 31, 2022 | -191.21% |
| Sep 30, 2022 | -284.72% |
| Jun 30, 2022 | -208.82% |
| Mar 31, 2022 | -345.32% |
| Dec 31, 2021 | 73.75% |
| Sep 30, 2021 | -189.79% |
| Jun 30, 2021 | -261.58% |
API Access
Regenxbio Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();